Eastern Platinum Ltd. T.ELR

Alternate Symbol(s): ELRFF

Eastern Platinum Limited owns directly and indirectly a number of platinum group metals (PGM) and chrome assets in the Republic of South Africa. It is engaged in re-mining and processing of tailings at the Crocodile River Mine (CRM) and the exploration and development of other PGM and chrome properties located in various provinces in South Africa. All of the Company's properties are situated on the western limb (Crocodile River Mine) and eastern limb (Kennedy's Vale, Spitzkop, Mareesburg) of the Bushveld Complex, the geological environment that hosts approximately 80% of the PGM-bearing ore. Operations at the Crocodile River Mine include re-mining and processing its tailings resource to produce PGM and chrome concentrates from the Barplats Zandfontein tailings dam. Its six PGMs are platinum, palladium, rhodium, osmium, iridium and ruthenium. The Kennedy’s Vale and Spitzkop Project are situated on the Eastern limb of the Bushveld Complex 350 kilometers northeast of Johannesburg.

TSX:ELR - Post by User

Eastern Platinum Ltd.

Bullboard Posts

Comment by 13thon Feb 13, 2008 12:00am

360 Views

Post# 14364090

RE: pretty decent run

"""-----INNEXUS BIOTECHNOLOGY INC ( IXS.V )-----"""size=4>color=RED> MAJOR NEWS----InNexus says study shows DXL625 kills tumour cellssize=4> INNEXUS BIOTECHNOLOGY ( TRADING JUST AT 0.35 CENTS ) ANNOUNCES PRELIMINARY RESULTS OF ANIMAL STUDY COMPARING CANCER KILLING ACTIVITY OF ITS DXL625 (CD20) TREATMENT FOR NON-HODGKIN'S LYMPHOMA WITH LEADING MARKETED PRODUCT UP 200% AND RISING FAST,,HEDGE FUNDS ARE BUYING LARGEsize=4>color=RED> https://stockcharts.com/h-sc/ui?s=ixs.V&p=D&b=5&g=0&id=p95524307080 -PENDING NEWS OF 30 MILLION ROYALTY @ PRICE OF $ 1.01 GANA MAKE THIS STOCK FLY -DXL 625 is IXS's first drug offering that enhances or betters Rituxan a $2.06 Billion a year drug. -The animal testing results show that DXL 625 is more effective than Rituxan (remember a $2 Billion drug). -The CEO has indicated a 2nd drug is in the works and another $30 Million from Royalty will be soon be available to company @ price of $ 1.01 per share Show me another Biotech with this much going for it with such a low market cap. This thing is going to take off.------------- Recommandation *STRONG BUY* --------------size=4> THIS STOCK IS AT THE TOP OF THE PHARMACEUTICAL WORLD - PLACE YOUR BETS BUY LOW BEFORE HEADING TO DA MOOOOOOOOOON

Bullboard Posts

This junior mining stock offers billions in market exposure